Natco Pharma Limited (NATCOPHARM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Natco Pharma Limited (NATCOPHARM) has a cash flow conversion efficiency ratio of 0.138x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs11.91 Billion ≈ $128.76 Million USD) by net assets (Rs86.54 Billion ≈ $935.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Natco Pharma Limited for the company's overall valuation and market capitalisation.
Natco Pharma Limited - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how Natco Pharma Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Natco Pharma Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Natco Pharma Limited ranked by their cash flow conversion efficiency. Explore NATCOPHARM operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Atrium Ljungberg AB (publ)
ST:ATRLJ-B
|
0.005x |
|
Fujian Kuncai Material Tech
SHG:603826
|
0.061x |
|
Xintai Ntrl Gas
SHG:603393
|
0.044x |
|
NP3 Fastigheter AB
ST:NP3
|
0.016x |
|
China Eastern Airlines Corporation Limited
F:CIAH
|
0.231x |
|
Flight Centre Travel Group Ltd
AU:FLT
|
-0.051x |
|
Beijing Caishikou Department Store Co Ltd
SHG:605599
|
0.091x |
|
BW Energy Ltd
OL:BWE
|
0.315x |
Annual Cash Flow Conversion Efficiency for Natco Pharma Limited (2005–2025)
The table below shows the annual cash flow conversion efficiency of Natco Pharma Limited from 2005 to 2025. View Natco Pharma Limited (NATCOPHARM) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs76.12 Billion ≈ $823.24 Million |
Rs16.97 Billion ≈ $183.50 Million |
0.223x | +4.18% |
| 2024-03-31 | Rs58.53 Billion ≈ $632.99 Million |
Rs12.52 Billion ≈ $135.43 Million |
0.214x | +130.24% |
| 2023-03-31 | Rs91.37 Billion ≈ $988.18 Million |
Rs8.49 Billion ≈ $91.83 Million |
0.093x | +752.04% |
| 2022-03-31 | Rs42.64 Billion ≈ $461.09 Million |
Rs465.00 Million ≈ $5.03 Million |
0.011x | -84.95% |
| 2021-03-31 | Rs41.23 Billion ≈ $445.93 Million |
Rs2.99 Billion ≈ $32.31 Million |
0.072x | -34.28% |
| 2020-03-31 | Rs37.85 Billion ≈ $409.30 Million |
Rs4.17 Billion ≈ $45.13 Million |
0.110x | -42.45% |
| 2019-03-31 | Rs34.91 Billion ≈ $377.54 Million |
Rs6.69 Billion ≈ $72.33 Million |
0.192x | +27.11% |
| 2018-03-31 | Rs30.76 Billion ≈ $332.66 Million |
Rs4.64 Billion ≈ $50.14 Million |
0.151x | -27.94% |
| 2017-03-31 | Rs16.53 Billion ≈ $178.81 Million |
Rs3.46 Billion ≈ $37.40 Million |
0.209x | +166.23% |
| 2016-03-31 | Rs13.03 Billion ≈ $140.94 Million |
Rs1.02 Billion ≈ $11.07 Million |
0.079x | -27.85% |
| 2015-03-31 | Rs8.51 Billion ≈ $92.04 Million |
Rs926.66 Million ≈ $10.02 Million |
0.109x | -44.61% |
| 2014-03-31 | Rs7.33 Billion ≈ $79.24 Million |
Rs1.44 Billion ≈ $15.58 Million |
0.197x | +74.77% |
| 2013-03-31 | Rs5.44 Billion ≈ $58.84 Million |
Rs611.95 Million ≈ $6.62 Million |
0.112x | -18.24% |
| 2012-03-31 | Rs4.72 Billion ≈ $51.05 Million |
Rs649.41 Million ≈ $7.02 Million |
0.138x | -28.06% |
| 2011-03-31 | Rs3.53 Billion ≈ $38.23 Million |
Rs675.97 Million ≈ $7.31 Million |
0.191x | -23.21% |
| 2010-03-31 | Rs3.11 Billion ≈ $33.60 Million |
Rs773.69 Million ≈ $8.37 Million |
0.249x | +77.24% |
| 2009-03-31 | Rs2.66 Billion ≈ $28.77 Million |
Rs373.85 Million ≈ $4.04 Million |
0.141x | -34.64% |
| 2008-03-31 | Rs2.25 Billion ≈ $24.34 Million |
Rs483.90 Million ≈ $5.23 Million |
0.215x | -11.13% |
| 2007-03-31 | Rs1.86 Billion ≈ $20.12 Million |
Rs450.03 Million ≈ $4.87 Million |
0.242x | +19.35% |
| 2006-03-31 | Rs1.54 Billion ≈ $16.64 Million |
Rs311.81 Million ≈ $3.37 Million |
0.203x | -52.96% |
| 2005-03-31 | Rs1.14 Billion ≈ $12.29 Million |
Rs489.69 Million ≈ $5.30 Million |
0.431x | -- |
About Natco Pharma Limited
NATCO Pharma Limited, a pharmaceutical company, engages in the research and development, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; a… Read more